Phase II Study of Pembrolizumab Efficacy and Safety in Women with Recurrent Small Cell Neuroendocrine Carcinoma of the Lower Genital Tract

OBJECTIVE: To investigate the efficacy and safety of pembrolizumab in women with recurrent small cell neuroendocrine tumors of the lower genital tract. METHODS: We conducted an open-label, investigator-initiated phase II basket trial of pembrolizumab 200 mg intravenously every 3 weeks in patients wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gynecol Oncol
Main Authors: Frumovitz, Michael, Westin, Shannon N., Salvo, Gloria, Zarifa, Abdulrazzak, Xu, Mingxuan, Yap, Timothy A., Rodon, Ahnert J., Karp, Daniel D., Abonofal, Abdulrahman, Jazaeri, Amir A., Naing, Aung
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7486997/
https://ncbi.nlm.nih.gov/pubmed/32534809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2020.05.682
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados